The Effect of Protandim Supplementation on Oxidative Damage and Athletic Performance
NCT ID: NCT02172625
Last Updated: 2019-02-12
Study Results
Results available
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
40 participants
Study Classification
INTERVENTIONAL
Study Start Date
2014-11-30
Study Completion Date
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Nutrition supplementation with antioxidants have been discussed as a way to further enhance overall well-being of athletes, promote faster recovery, and improve overall performance. The use of Protandim, a nutritional supplement containing 5 botanicals (Bacopa extract 150 mg; milk thistle 225mg; ashwagandha 150 mg; green tea 75 mg; turmeric 75 mg) has shown promise in an earlier study by reducing oxidative stress and increasing the amount of the anti-oxidant enzymes in the blood.
The purpose of this study was to examine the effect of \~90 day Protandim supplementation on 5-km running performance and on acute and long term oxidative damage as assessed by blood markers. Secondarily, another purpose of this study examined the effect of Protandim supplementation on other blood parameters (such as antioxidant enzyme concentrations) and measures of quality of life. The experiment was double-blind, placebo controlled. The study addressed two main questions and two secondary questions:
Main Question 1: Does regular supplementation of Protandim (675 mg/day for 90 days) improve 5-km running times? Hypothesis: Protandim would improve 5-km running time by 0.5 min (SD 1-min). This is equivalent to an effect size of 0.5. The placebo group will have no change in performance.
Main Question 2: Does regular supplementation of Protandim (675 mg/day for 90 days) reduce oxidative damage at rest as assessed by lipid peroxides (TBARS) in runners? Hypothesis: Based on the data by Nelson et al. (2006), oxidative damaged would be reduced by 40% (effect size = 4.8).
Secondary Question 1: Does regular supplementation of Protandim (675 mg/day for 90 days) in runners reduce the increase in oxidative damage post-race compared to pre-race as assessed by lipid peroxides (TBARS)? Hypothesis: Based on the data by Kyparos et al. (2009), we expected a 45% increase in TBARS post-exercise compared to pre-exercise (effect size of 3.6). However, we expected that those that are on Protandim for 90 days will only have 31% increase in TBARS post-race (effect size = 2.5) \[based on changes in pre-post lipid peroxides from Arent et al. (2010)\].
Secondary Question 2: Does regular supplementation of Protandim (675 mg/day for 90 days) improve quality of life according to WHOQOL-BREF (Skevington, Lotfy, O'Connell, \& Group, 2004)? Hypothesis: There would be a statistical improvement in the quality of life post-Protandim supplementation which a small effect size improvement of 0.33.
The purpose of this study was to examine the effect of \~90 day Protandim supplementation on 5-km running performance and on acute and long term oxidative damage as assessed by blood markers. Secondarily, another purpose of this study examined the effect of Protandim supplementation on other blood parameters (such as antioxidant enzyme concentrations) and measures of quality of life. The experiment was double-blind, placebo controlled. The study addressed two main questions and two secondary questions:
Main Question 1: Does regular supplementation of Protandim (675 mg/day for 90 days) improve 5-km running times? Hypothesis: Protandim would improve 5-km running time by 0.5 min (SD 1-min). This is equivalent to an effect size of 0.5. The placebo group will have no change in performance.
Main Question 2: Does regular supplementation of Protandim (675 mg/day for 90 days) reduce oxidative damage at rest as assessed by lipid peroxides (TBARS) in runners? Hypothesis: Based on the data by Nelson et al. (2006), oxidative damaged would be reduced by 40% (effect size = 4.8).
Secondary Question 1: Does regular supplementation of Protandim (675 mg/day for 90 days) in runners reduce the increase in oxidative damage post-race compared to pre-race as assessed by lipid peroxides (TBARS)? Hypothesis: Based on the data by Kyparos et al. (2009), we expected a 45% increase in TBARS post-exercise compared to pre-exercise (effect size of 3.6). However, we expected that those that are on Protandim for 90 days will only have 31% increase in TBARS post-race (effect size = 2.5) \[based on changes in pre-post lipid peroxides from Arent et al. (2010)\].
Secondary Question 2: Does regular supplementation of Protandim (675 mg/day for 90 days) improve quality of life according to WHOQOL-BREF (Skevington, Lotfy, O'Connell, \& Group, 2004)? Hypothesis: There would be a statistical improvement in the quality of life post-Protandim supplementation which a small effect size improvement of 0.33.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating a Natural Antioxidant Food Product on Oxidative Stress in Recreationally Active Participants
NCT04959006
Oxidative Stress
Exercise Recovery
COMPLETED
NA
ABG Oxidative Stress Study Protocol-1
NCT02213523
Healthy
COMPLETED
NA
Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
NCT02134756
Performance
Fatigue
COMPLETED
NA
Examining Endogenous Antioxidant Levels in Well Trained Cyclists
NCT02281851
Oxidative Stress
COMPLETED
A Randomized, Double-Blind Study to Assess the Effect of a Postbiotic on Oxidative Stress and Exercise Performance
NCT06795425
Oxidative Stress
Healthy
Exercise-induced Muscle Damage
+6 more
NOT_YET_RECRUITING
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Forty apparently healthy community runners 18-55 yrs of age was recruited to participate in this study that will require six total visits to the University of Louisville, which included three sessions at the running track at University of Louisville.
A about 120 mL of blood was withdrawn from a peripheral vein for the duration of the study (about 105 days). Runners was recruited from running clubs across the local community. These participants will be randomized into two groups (Protandim, Placebo). The groups will be sex and performance matched after the initial 5-km race.
Each subject underwent six testing sessions.
Session 1 (Initial Screening Day)
Subjects signed consent form and completed a questionnaire to clear them for physical activity. Age, weight, and height was recorded. Subjects was asked to list all the nutritional supplements they are taking, including multivitamins. They were asked to list the 5-km personal best time, and when that was done. They reported most recent 5-km time and when that was achieved. Then they were asked to refrain from taking any multivitamins or nutritional supplements for the duration of the study. The subjects recorded what they ate during the 24 hr prior to the test day, and then they were asked to eat the same thing and do same activity before the all follow up tests. Then a training diary was given to them to fill in for the duration of the study. The training diary included intensity, training duration, and mileage per week. After, they were given six quality of life questionnaires \[World Health Organization's WHOQOL-BREF quality of life assessment to fill out at home (one each for Session 1-6)\]. A pregnancy test was also conducted in the females.
Session 2 (Baseline, About 15 days after Session 1)
Subjects were fasted in the morning when they arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. Approximately three teaspoons of blood was withdrawn 30-60 minutes prior to exercise for analysis of several blood parameters. Then subjects were required to partake in a 5-km time trial at the University of Louisville track. The runners raced together in groups of 6 to 10 runners per race according to their estimated 5-km time. The estimated 5-km time is their own best estimate. Time trials have greater logical validity compared to time-to-exhaustion tests so that is why time-trials are selected as the performance measure.
About 10-20 minutes post-exercise, another three teaspoons of blood was withdrawn from each subject. Only after their post-exercise blood draw will the subjects be able to eat.
Based on the performance of the 5-km time trials, males and females were ranked separately. This was done in randomized blocks of two for males, and then randomized into blocks of two for females. For example, the males was ranked from the 5-km race from the fastest runner to the slowest runner. First and second place males were placed in a block of two. Third and fourth place males were placed in a block of two. And so on. Then a fair coin was flipped. If heads, the first ranked runner in the first pair went to Group 1, otherwise, the second ranked runner in the pair went to Group 1. This was done for each block of two males (each pair of two males). The same is then performed for the women. This randomization allowed for the same mean 5-km running times in each group as well as maintaining similar male to female ratios.
Session 3 (About 7 days after Session 2)
Subjects were fasted in the morning when arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. Approximately three teaspoons of blood were withdrawn 30-60 minutes prior to exercise for analysis of several blood parameters (the analytes are listed in Table 3). Then subjects partook in a 5-km time trial at the University of Louisville track.
About 30-minutes post-exercise, another three teaspoons of blood were withdrawn from each subject. Only after their post-exercise blood draw were the subjects be able to eat.
Depending on the group, they were given approximately a 100 day supply of Protandim or Placebo (corn starch and food coloring). The study was double blinded so neither the researchers nor the subjects knew which group is the Protandim group and which group was the Placebo group. They ingested 1 pill per day, ideally with breakfast (675 mg per day, 1 pill per day). The subjects were given the complete supply of pills during this session, right after the second blood sample was taken. The subjects was classified as Group 1 or Group 2 based on their five kilometer results from the first session. The pill bottles were labeled Group 1 or Group 2. The pill bottles were dispensed by the research team according to group number after their second blood sample. Subjects were asked record the daily intake of the pills in their training diary. Once the study was completed, subjects were asked to return the pill bottles to the research staff. That way, the researchers were able to account for any missed days.
Session 4 (About 23 Days after Session 3)
Subjects were fasted in the morning when arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. Approximately three teaspoons of blood were withdrawn. There was no 5-km running race performed in this session. A pregnancy test was performed in the females.
Session 5 (about 30 Days after Session 4)
Subjects were fasted in the morning when they arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. Approximately three teaspoons of blood were withdrawn. There was no running race performed in this session. A pregnancy test was conducted in the females.
Session 6 (About 30 days after Session 5)
Subjects were fasted in the morning when they arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. They also brought any unused pills for proper documentation. A pregnancy test was conducted in the females. Then, approximately three teaspoons of blood were withdrawn 30-60 minutes prior to exercise for analysis of several blood parameters. Then subjects partook in a 5-km time trial at the University of Louisville track.
About 30-minutes post-exercise, another three teaspoons of blood was withdrawn from each subject. Only after their post-exercise blood draw were the subjects be able to eat.
Things to Consider: The between subject-variability in oxidative stress biomarkers is large (Mullins et al. 2013) and suggests that there may be responders and non-responders to an oxidative stress challenge (Mullins et al. 2013). Individuals who have large increases in oxidative stress (i.e. responders) could be reflecting an inability to regulate redox homeostasis and warrant additional support (i.e. with antioxidant supplementation with Protandim). It is also necessary to obtain week-to week and month to month coefficient of variation in markers of oxidative stress so that meaningful changes in these markers can be evaluated. Thus, the placebo group allowed us to obtain the week-to-week and month to month coefficient of variation. As well, for the same reason, it is necessary to obtain week-to-week and month to month variation in running performance, thus, the placebo group will allow for the development of the coefficient of variation in performance.
Measuring dietary data is troublesome. First, questionnaires don't give details about antioxidant intake - rather they give outcomes like fruit and veg intake, etc. More in depth measures wouldn't be worth the trouble. Thus, having subjects record what they eat (and their physical activity) during the 24 hr prior to the test day, and then having to ask them to eat the same thing and do same activity before the follow up tests at seven days and 90 days was required.
Environmental conditions was recorded on the days of the three time trials (wind, temperature, % humidity, barometric pressure).
Statistical Analyses
Once all the data was collected and analyzed, LifeVantage revealed which group was which. The main dependent variables measured were the 5-km finishing time, TBARS, SOD, and both the quality of life questionnaire. Based on a 5-km time improvement of 2.5% or about 30 seconds (SD = 1 minute) with Protandim, and no improvement in the placebo group, about 32 runners in total would be needed (Effect size = 0.5, statistical power = 80%, alpha error probability = 5%, Correlation amongst repeated measures = 0.90, F-test Family, ANOVA repeated measures, between factors, G\*Power 3.1.2, Universität Kiel, Germany). Accounting for a 20% attrition rate (8 subjects), a total of 40 subjects were recruited (20 per group).
Possible Risks of Ingesting Protandim: We did expect there to be any side effects for the typical Protandim consumer. However, according to the Protandim website (http://www.protandim.com/faqs), some individuals have natural allergic responses to one of the ingredients, just as some people are allergic to pine pollen or penicillin. These allergic responses to Protandim generally appear as gastrointestinal disturbances (i.e., stomach ache, diarrhea, vomiting) or sometimes as a headache or rash on the hands or feet. The symptoms disappear if Protandim is discontinued. However, according to the Natural Standard Database (https://naturalmedicines.therapeuticresearch.com/), each botanical has been shown to have rare side effects. They are listed there.
A about 120 mL of blood was withdrawn from a peripheral vein for the duration of the study (about 105 days). Runners was recruited from running clubs across the local community. These participants will be randomized into two groups (Protandim, Placebo). The groups will be sex and performance matched after the initial 5-km race.
Each subject underwent six testing sessions.
Session 1 (Initial Screening Day)
Subjects signed consent form and completed a questionnaire to clear them for physical activity. Age, weight, and height was recorded. Subjects was asked to list all the nutritional supplements they are taking, including multivitamins. They were asked to list the 5-km personal best time, and when that was done. They reported most recent 5-km time and when that was achieved. Then they were asked to refrain from taking any multivitamins or nutritional supplements for the duration of the study. The subjects recorded what they ate during the 24 hr prior to the test day, and then they were asked to eat the same thing and do same activity before the all follow up tests. Then a training diary was given to them to fill in for the duration of the study. The training diary included intensity, training duration, and mileage per week. After, they were given six quality of life questionnaires \[World Health Organization's WHOQOL-BREF quality of life assessment to fill out at home (one each for Session 1-6)\]. A pregnancy test was also conducted in the females.
Session 2 (Baseline, About 15 days after Session 1)
Subjects were fasted in the morning when they arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. Approximately three teaspoons of blood was withdrawn 30-60 minutes prior to exercise for analysis of several blood parameters. Then subjects were required to partake in a 5-km time trial at the University of Louisville track. The runners raced together in groups of 6 to 10 runners per race according to their estimated 5-km time. The estimated 5-km time is their own best estimate. Time trials have greater logical validity compared to time-to-exhaustion tests so that is why time-trials are selected as the performance measure.
About 10-20 minutes post-exercise, another three teaspoons of blood was withdrawn from each subject. Only after their post-exercise blood draw will the subjects be able to eat.
Based on the performance of the 5-km time trials, males and females were ranked separately. This was done in randomized blocks of two for males, and then randomized into blocks of two for females. For example, the males was ranked from the 5-km race from the fastest runner to the slowest runner. First and second place males were placed in a block of two. Third and fourth place males were placed in a block of two. And so on. Then a fair coin was flipped. If heads, the first ranked runner in the first pair went to Group 1, otherwise, the second ranked runner in the pair went to Group 1. This was done for each block of two males (each pair of two males). The same is then performed for the women. This randomization allowed for the same mean 5-km running times in each group as well as maintaining similar male to female ratios.
Session 3 (About 7 days after Session 2)
Subjects were fasted in the morning when arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. Approximately three teaspoons of blood were withdrawn 30-60 minutes prior to exercise for analysis of several blood parameters (the analytes are listed in Table 3). Then subjects partook in a 5-km time trial at the University of Louisville track.
About 30-minutes post-exercise, another three teaspoons of blood were withdrawn from each subject. Only after their post-exercise blood draw were the subjects be able to eat.
Depending on the group, they were given approximately a 100 day supply of Protandim or Placebo (corn starch and food coloring). The study was double blinded so neither the researchers nor the subjects knew which group is the Protandim group and which group was the Placebo group. They ingested 1 pill per day, ideally with breakfast (675 mg per day, 1 pill per day). The subjects were given the complete supply of pills during this session, right after the second blood sample was taken. The subjects was classified as Group 1 or Group 2 based on their five kilometer results from the first session. The pill bottles were labeled Group 1 or Group 2. The pill bottles were dispensed by the research team according to group number after their second blood sample. Subjects were asked record the daily intake of the pills in their training diary. Once the study was completed, subjects were asked to return the pill bottles to the research staff. That way, the researchers were able to account for any missed days.
Session 4 (About 23 Days after Session 3)
Subjects were fasted in the morning when arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. Approximately three teaspoons of blood were withdrawn. There was no 5-km running race performed in this session. A pregnancy test was performed in the females.
Session 5 (about 30 Days after Session 4)
Subjects were fasted in the morning when they arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. Approximately three teaspoons of blood were withdrawn. There was no running race performed in this session. A pregnancy test was conducted in the females.
Session 6 (About 30 days after Session 5)
Subjects were fasted in the morning when they arrived at University of Louisville for their pre-exercise blood sampling. They brought their 24-hr dietary recall with them and their quality of life forms. They also brought any unused pills for proper documentation. A pregnancy test was conducted in the females. Then, approximately three teaspoons of blood were withdrawn 30-60 minutes prior to exercise for analysis of several blood parameters. Then subjects partook in a 5-km time trial at the University of Louisville track.
About 30-minutes post-exercise, another three teaspoons of blood was withdrawn from each subject. Only after their post-exercise blood draw were the subjects be able to eat.
Things to Consider: The between subject-variability in oxidative stress biomarkers is large (Mullins et al. 2013) and suggests that there may be responders and non-responders to an oxidative stress challenge (Mullins et al. 2013). Individuals who have large increases in oxidative stress (i.e. responders) could be reflecting an inability to regulate redox homeostasis and warrant additional support (i.e. with antioxidant supplementation with Protandim). It is also necessary to obtain week-to week and month to month coefficient of variation in markers of oxidative stress so that meaningful changes in these markers can be evaluated. Thus, the placebo group allowed us to obtain the week-to-week and month to month coefficient of variation. As well, for the same reason, it is necessary to obtain week-to-week and month to month variation in running performance, thus, the placebo group will allow for the development of the coefficient of variation in performance.
Measuring dietary data is troublesome. First, questionnaires don't give details about antioxidant intake - rather they give outcomes like fruit and veg intake, etc. More in depth measures wouldn't be worth the trouble. Thus, having subjects record what they eat (and their physical activity) during the 24 hr prior to the test day, and then having to ask them to eat the same thing and do same activity before the follow up tests at seven days and 90 days was required.
Environmental conditions was recorded on the days of the three time trials (wind, temperature, % humidity, barometric pressure).
Statistical Analyses
Once all the data was collected and analyzed, LifeVantage revealed which group was which. The main dependent variables measured were the 5-km finishing time, TBARS, SOD, and both the quality of life questionnaire. Based on a 5-km time improvement of 2.5% or about 30 seconds (SD = 1 minute) with Protandim, and no improvement in the placebo group, about 32 runners in total would be needed (Effect size = 0.5, statistical power = 80%, alpha error probability = 5%, Correlation amongst repeated measures = 0.90, F-test Family, ANOVA repeated measures, between factors, G\*Power 3.1.2, Universität Kiel, Germany). Accounting for a 20% attrition rate (8 subjects), a total of 40 subjects were recruited (20 per group).
Possible Risks of Ingesting Protandim: We did expect there to be any side effects for the typical Protandim consumer. However, according to the Protandim website (http://www.protandim.com/faqs), some individuals have natural allergic responses to one of the ingredients, just as some people are allergic to pine pollen or penicillin. These allergic responses to Protandim generally appear as gastrointestinal disturbances (i.e., stomach ache, diarrhea, vomiting) or sometimes as a headache or rash on the hands or feet. The symptoms disappear if Protandim is discontinued. However, according to the Natural Standard Database (https://naturalmedicines.therapeuticresearch.com/), each botanical has been shown to have rare side effects. They are listed there.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Oxidative Stress
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
SUPPORTIVE_CARE
Blinding Strategy
DOUBLE
Participants
Investigators
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo Group
Corn starch and food coloring is the placebo comparator. Each subject will ingest 675 mg (1 pill) per day of the placebo comparator
Group Type
PLACEBO_COMPARATOR
Placebo Group
Intervention Type
OTHER
This was a randomized, block design, controlling for 5-km performance and sex. Subjects were given 675 mg per day (1 pill per day) of corn starch for 90 days. Subjects ran a 5-km time trial before and after the supplementation period. Blood samples were taken pre and post supplementation.
Protandim Dietary Supplement
Each subject will ingest 675 mg per day (1 pill) of Protandim for about 90 days. Each pill contains 5 botanicals (Bacopa extract 150 mg, milk thistle 225mg, ashwagandha 150 mg, green tea 75 mg, turmeric 75 mg).
Group Type
EXPERIMENTAL
Protandim Dietary Supplement
Intervention Type
DIETARY_SUPPLEMENT
This was a randomized, block design, controlling for 5-km performance and sex. Subjects were given 675 mg per day (1 pill per day) of Protandim for 90 days. Subjects ran a 5-km time trial before and after the supplementation period. Blood samples were taken pre and post supplementation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protandim Dietary Supplement
This was a randomized, block design, controlling for 5-km performance and sex. Subjects were given 675 mg per day (1 pill per day) of Protandim for 90 days. Subjects ran a 5-km time trial before and after the supplementation period. Blood samples were taken pre and post supplementation.
Intervention Type
DIETARY_SUPPLEMENT
Placebo Group
This was a randomized, block design, controlling for 5-km performance and sex. Subjects were given 675 mg per day (1 pill per day) of corn starch for 90 days. Subjects ran a 5-km time trial before and after the supplementation period. Blood samples were taken pre and post supplementation.
Intervention Type
OTHER
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Protandim Group
Experimental Group
Control Group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Healthy, non-pregnant subjects between 18 and 55 years of age. Apparently healthy is classified as A-1, A-2, or A-3 according to the American Heart Association
http://circ.ahajournals.org/content/97/22/2283/T6.expansion.html
2. Subjects have to achieve a classification of "local class" based on age-graded time USA Track \& Field. The age-graded time is the finish time adjusted to that of an open division participant using a factor for age and gender. Thus, the times for women and older participants are adjusted downward, while the times for most open division participants (such as 25-year-old men) remain the same. For example, a 55 year old woman has to run 29 minutes 45 seconds or better to be in the study:
http://www.usatf.org/statistics/calculators/agegrading/
For a man the same age, the equivalent time would be 25 minutes 2 seconds. This is approximately 60% of the speed of the current world record time for that age.
3. Subjects who will abstain from taking any nutritional supplements for the duration of the study, including vitamins and mineral supplements (Exception, ferrous sulfate, elemental iron, Vitamin D, Calcium). Subjects will also abstain from taking any over the counter products (herbals, melatonin, St. John's Wort, etc…) for the duration of the study.
http://circ.ahajournals.org/content/97/22/2283/T6.expansion.html
2. Subjects have to achieve a classification of "local class" based on age-graded time USA Track \& Field. The age-graded time is the finish time adjusted to that of an open division participant using a factor for age and gender. Thus, the times for women and older participants are adjusted downward, while the times for most open division participants (such as 25-year-old men) remain the same. For example, a 55 year old woman has to run 29 minutes 45 seconds or better to be in the study:
http://www.usatf.org/statistics/calculators/agegrading/
For a man the same age, the equivalent time would be 25 minutes 2 seconds. This is approximately 60% of the speed of the current world record time for that age.
3. Subjects who will abstain from taking any nutritional supplements for the duration of the study, including vitamins and mineral supplements (Exception, ferrous sulfate, elemental iron, Vitamin D, Calcium). Subjects will also abstain from taking any over the counter products (herbals, melatonin, St. John's Wort, etc…) for the duration of the study.
Exclusion Criteria
1. Under 18 and over 55 years of age; those who are not apparently healthy is classified as A-1, A-2, or A-3 according to the American Heart Association.
2. Subjects who are not able to run 5-km in the time required for their age and gender.
3. Subjects that will continue to take nutritional supplements, including over the counter products, for the duration of the study, including vitamins and mineral supplements (exception: Ferrous sulfate, Elemental iron, Vitamin D, Calcium).
4. Subjects that are taking prescription medications with the exception of birth control.
5. Known allergy or sensitivity to milk thistle, Bacopa monnieri, Ashwagandha, turmeric (or ginger), tea, its parts, caffeine, tannins, or members of the Theaceae family.
2. Subjects who are not able to run 5-km in the time required for their age and gender.
3. Subjects that will continue to take nutritional supplements, including over the counter products, for the duration of the study, including vitamins and mineral supplements (exception: Ferrous sulfate, Elemental iron, Vitamin D, Calcium).
4. Subjects that are taking prescription medications with the exception of birth control.
5. Known allergy or sensitivity to milk thistle, Bacopa monnieri, Ashwagandha, turmeric (or ginger), tea, its parts, caffeine, tannins, or members of the Theaceae family.
Minimum Eligible Age
18 Years
Maximum Eligible Age
55 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Louisville
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gerald S Zavorsky, PhD
Associate Professor
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerald S Zavorsky, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Louisville
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Crawford Gym, Room 17a, University of Louisville
Louisville, Kentucky, United States
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United States
References
Explore related publications, articles, or registry entries linked to this study.
Arent SM, Pellegrino JK, Williams CA, Difabio DA, Greenwood JC. Nutritional supplementation, performance, and oxidative stress in college soccer players. J Strength Cond Res. 2010 Apr;24(4):1117-24. doi: 10.1519/JSC.0b013e3181cb70b8.
Reference Type
BACKGROUND
Kyparos A, Vrabas IS, Nikolaidis MG, Riganas CS, Kouretas D. Increased oxidative stress blood markers in well-trained rowers following two thousand-meter rowing ergometer race. J Strength Cond Res. 2009 Aug;23(5):1418-26. doi: 10.1519/JSC.0b013e3181a3cb97.
Reference Type
BACKGROUND
Kabasakalis A, Kyparos A, Tsalis G, Loupos D, Pavlidou A, Kouretas D. Blood oxidative stress markers after ultramarathon swimming. J Strength Cond Res. 2011 Mar;25(3):805-11. doi: 10.1519/JSC.0b013e3181d0b109.
Reference Type
BACKGROUND
Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med. 2006 Jan 15;40(2):341-7. doi: 10.1016/j.freeradbiomed.2005.08.043.
Reference Type
BACKGROUND
Mullins AL, van Rosendal SP, Briskey DR, Fassett RG, Wilson GR, Coombes JS. Variability in oxidative stress biomarkers following a maximal exercise test. Biomarkers. 2013 Aug;18(5):446-54. doi: 10.3109/1354750X.2013.810668.
Reference Type
BACKGROUND
Jeukendrup AE, Currell K. Should time trial performance be predicted from three serial time-to-exhaustion tests? Med Sci Sports Exerc. 2005 Oct;37(10):1820; author reply 1821. doi: 10.1249/01.mss.0000175095.56646.4b. No abstract available.
Reference Type
BACKGROUND
Ueberschlag SL, Seay JR, Roberts AH, DeSpirito PC, Stith JM, Folz RJ, Carter KA, Weiss EP, Zavorsky GS. The Effect of Protandim(R) Supplementation on Athletic Performance and Oxidative Blood Markers in Runners. PLoS One. 2016 Aug 11;11(8):e0160559. doi: 10.1371/journal.pone.0160559. eCollection 2016.
Reference Type
RESULT
Related Links
Access external resources that provide additional context or updates about the study.
http://www.lifevantage.com/products/protandim/
Protandim Web-link
https://naturalmedicines.therapeuticresearch.com/
Natural Standards Database
http://www.usatf.org/statistics/calculators/agegrading/
Age-Gender Performance Grading for 5-km
http://circ.ahajournals.org/content/97/22/2283/T6.expansion.html
Recommendations for Cardiovascular Screening
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14.0614
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Probiotic Sport Study
NCT01474629
COMPLETED
NA
Oxidative Stress as an Acute Exercise-induced Mechanism of Stem and Progenitor Cell Mobilization
NCT03747913
COMPLETED
NA
Medium-Term Supplementation With Herbal Extract for Exercise Performance and Antioxidant Status
NCT04263246
COMPLETED
NA
A Study to Assess the Impact of a Nutritional Supplement on Wellbeing and Nutrient Absorption
NCT06749808
ENROLLING_BY_INVITATION
NA
The Effect of Postbiotics Supplementation on Exercise-induced Oxidative Stress.
NCT06417671
COMPLETED
NA
Effects of Plant Concentrate Blend on Oxidative Stress in Healthy Humans
NCT02213588
COMPLETED
NA
Evaluation of Astaxanthin Properties on Anti-fatigue
NCT06593535
COMPLETED
NA
The Effects of Antioxidant Supplementation on Multiple Endurance Race Performance, Physiology, and Recovery.
NCT04314596
COMPLETED
NA
The Effect of Antioxidant Vitamin Supplementation on Muscle Performance and Redox Status After Eccentric Training
NCT01290458
COMPLETED
NA
Ashwagandha Supplementation for Prevention of Muscle Damage
NCT06900569
RECRUITING
NA
Efficacy Of "Prodovite®" In Athletic Performance
NCT04734834
UNKNOWN
NA
Effects of Antioxidants and B Vitamins Supplements on Inflammation in Obese Diabetic Patients
NCT01691365
COMPLETED
PHASE4
The Effects of Ashwagandha in Endurance Exercise Performance
NCT03596307
UNKNOWN
NA
Oxidative Stress Links Aging, Activity, and Mobility Limitation
NCT01177189
TERMINATED
NA
Ischemia Reperfusion: Prostaglandins and Antioxidants
NCT01666587
COMPLETED
NA
Clinical Study on Prodovite® VMP35 Supplement on Athletic Performance
NCT04121481
UNKNOWN
NA
Assessment of a Pre-Workout Dietary Supplement
NCT02952014
COMPLETED
NA
Exercise and NutraStem (NT-020): Effects on Stem Cells
NCT01847027
COMPLETED
PHASE2
Turmeric and Exercise-Induced Muscle Damage and Oxinflammation
NCT04765527
COMPLETED
NA
Effects of Herbal Supplements on Endurance Exercise Performance
NCT03929575
COMPLETED
NA
Effects of Astaxanthin Supplementation
NCT06511960
COMPLETED
NA
Seaweed Extract Supplementation and Metabolic Biomarkers
NCT03853343
COMPLETED
NA
The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery.
NCT06274385
RECRUITING
NA
Minerals and Botanicals for Acute Stress
NCT03262376
COMPLETED
NA
Astaxanthin Supplementation in Cyclists
NCT01241877
UNKNOWN
NA